Skip to main content
Deep Health AI India Limited logo

Deep Health AI India Limited — Investor Relations & Filings

Ticker · 539559 ISIN · INE005G01026 BSE.NS Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 10 across all filing types
Latest filing 2026-05-31 Report Publication Anno…
Country IN India
Listing BSE.NS 539559

About Deep Health AI India Limited

https://deephealthaiindia.com/

Deep Health AI India Limited specializes in the development and implementation of advanced artificial intelligence solutions tailored for medical imaging and diagnostic radiology. The company leverages deep learning algorithms to enhance the accuracy and efficiency of clinical workflows, particularly in the early detection of complex conditions such as breast and lung cancer. Its portfolio includes AI-driven software platforms designed to assist radiologists by automating routine tasks, prioritizing urgent cases, and providing quantitative analysis of medical scans. By integrating these technologies into existing healthcare infrastructures, the organization aims to improve diagnostic precision, reduce interpretation times, and optimize patient outcomes. The company serves a diverse range of healthcare providers, including diagnostic centers and hospital networks, focusing on scalable, data-driven health technology.

Recent filings

Filing Released Lang Actions
Pursuant to Regulations 33 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 please find enclosed a copy of the newspaper publication ....
Report Publication Announcement Classification · 85% confidence The document is an exchange intimation under SEBI LODR Regulations 33 and 47, enclosing a newspaper advertisement of the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. It does not itself contain detailed financial statements but announces the publication of the results in newspapers. This fits the definition of a Report Publication Announcement, as it is informing the regulator and market of the release/publication of a report rather than being the report itself.
2026-05-31 English
Pursuant to Regulations 33 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 please find enclosed a copy of the newspaper publication ....
Report Publication Announcement Classification · 45% confidence The document is an exchange filing under SEBI LODR regulations (Reg 33 & 47) notifying the stock exchange of the newspaper advertisement of the company’s audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. It does not include the actual financial statements but announces their publication in newspapers. Under the “menu vs meal” rule, this is not the report itself but a publication announcement. Therefore, it should be classified as a Report Publication Announcement (RPA).
2026-05-31 English
Financial Results for the quarter and year ended March 31, 2026. Further please note the below mentioned details of borrowing as system was not allowing us to take decimal: 1. Outstanding ....
Regulatory Filings Classification · 80% confidence The document is a stock exchange filing under SEBI Listing Regulations 30 and 33: a letter to BSE disclosing the revised outcome of the Board meeting, the approval of audited standalone and consolidated financial results, the appointment of an internal auditor, followed by the full Independent Auditor’s Report on the standalone financial statements. It is not a full annual report (10-K) nor a simple earnings release, but a regulatory announcement comprising both the board resolution and the audit report. It therefore best fits the general “Regulatory Filings” category for miscellaneous compliance announcements (RNS).
2026-05-30 English
Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of Deep Health ....
Audit Report / Information Classification · 92% confidence The document is a SEBI Listing Regulation 30/33 intimation to BSE containing the approved audited standalone and consolidated financial results for the year ended March 31, 2026, along with the full Independent Auditor’s Report (opinion, basis for opinion, key audit matters, etc.). This constitutes a standalone audit report rather than a mere earnings release or interim report and is not a certification-only letter or simple publication notice. Therefore, it fits the definition of an Audit Report / Information filing. FY 2026
2026-05-29 English
Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of Deep Health ....
Audit Report / Information Classification · 86% confidence The document is a statutory exchange filing under Regulation 30/33 (LODR), submitting the Board-approved Audited Standalone and Consolidated Financial Results for the year ended March 31, 2026, complete with the Independent Auditor’s Report. It is not a full corporate Annual Report (10-K), nor a brief earnings highlights release (ER), nor a simple report announcement (RPA). Instead, it comprises the standalone audit report itself, detailing opinion, basis of opinion, key audit matters, and audit procedures. This aligns precisely with our “Audit Report / Information” category (AR). FY 2026
2026-05-29 English
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation ....
Regulatory Filings Classification · 84% confidence The document is a compliance submission under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) 2015, providing the Statement of Deviation and Variation in the use of Rights Issue proceeds and the associated auditor certification. It is an announcement to the stock exchange with regulatory information rather than a standalone financial report (e.g., 10-K, IR) or a management presentation. There is no specific category for deviation statements in the taxonomy, so this should be classified as a general regulatory filing (RNS).
2026-05-29 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.